- Home
- NAUT vs COYA Comparison
NAUT vs COYA Comparison
Compare NAUT & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- COYA
- Stock Information
- Founded
- NAUT 2016
- COYA 2020
- Country
- NAUT United States
- COYA United States
- Employees
- NAUT N/A
- COYA N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- NAUT Industrials
- COYA Health Care
- Exchange
- NAUT Nasdaq
- COYA Nasdaq
- Market Cap
- NAUT 91.5M
- COYA 99.8M
- IPO Year
- NAUT N/A
- COYA 2022
- Fundamental
- Price
- NAUT $0.77
- COYA $6.13
- Analyst Decision
- NAUT Strong Sell
- COYA Strong Buy
- Analyst Count
- NAUT 1
- COYA 4
- Target Price
- NAUT $1.75
- COYA $16.50
- AVG Volume (30 Days)
- NAUT 561.4K
- COYA 71.0K
- Earning Date
- NAUT 07-29-2025
- COYA 08-11-2025
- Dividend Yield
- NAUT N/A
- COYA N/A
- EPS Growth
- NAUT N/A
- COYA N/A
- EPS
- NAUT N/A
- COYA N/A
- Revenue
- NAUT N/A
- COYA $3,685,107.00
- Revenue This Year
- NAUT N/A
- COYA $106.97
- Revenue Next Year
- NAUT N/A
- COYA N/A
- P/E Ratio
- NAUT N/A
- COYA N/A
- Revenue Growth
- NAUT N/A
- COYA N/A
- 52 Week Low
- NAUT $0.66
- COYA $4.65
- 52 Week High
- NAUT $3.09
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- NAUT 51.04
- COYA 57.80
- Support Level
- NAUT $0.69
- COYA $5.97
- Resistance Level
- NAUT $0.82
- COYA $6.45
- Average True Range (ATR)
- NAUT 0.06
- COYA 0.38
- MACD
- NAUT 0.00
- COYA 0.06
- Stochastic Oscillator
- NAUT 50.00
- COYA 69.05
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.